[email protected] Dear Mr. Epstein, I am a native New Yorker Columbia researcher with an appointment in Pathology who works in the new area of Phenomics as it applies to Lymphoma. I want to use this Translational Bioinformatic approach (LYMPS v.1.0) to identify new drug targets for DLBCL the deadlies